Case Study: Reimbursement Strategy for Lifesaving Cervical Dilator
Case Studies
Devices
Due Diligence
![](https://advi.com/wp-content/uploads/2022/08/case-12-566x204.png)
Commercial Contracting Process, Evaluations, and Metrics
![](https://advi.com/wp-content/uploads/2022/08/case-07.png)
Payer/KOL P&R Input to New Oncology Biologic Development Plan
![](https://advi.com/wp-content/uploads/2022/08/case-15-566x204.png)
Launch Planning and Implementation Support for Novel Biologic
Federal And State Policy
![](https://advi.com/wp-content/uploads/2022/08/case-13.png)
Case Study: Medicare Part D Liability Model
![](https://advi.com/wp-content/uploads/2022/08/case-13.png)
Case Study: Understanding the Impact of the MFPs for IPAY 2026
![](https://advi.com/wp-content/uploads/2022/08/case-13.png)
Case Study: Strengthening Positioning for IRA Drug Price Negotiation
![](https://advi.com/wp-content/uploads/2022/08/case-13.png)
Case Study: Demystifying the Evolving Policy Landscape for Oncology
![](https://advi.com/wp-content/uploads/2022/08/case-13.png)
Case Study: Navigating the Inflation Reduction Act
![](https://advi.com/wp-content/uploads/2022/08/case-01-566x204.png)
Evaluation of Biosimilar Utilization by Hospital Types
![](https://advi.com/wp-content/uploads/2022/08/case-02-566x204.png)
Advocacy Coalition for Uptake of Comprehensive Genomic Profiling
![](https://advi.com/wp-content/uploads/2022/08/case-03-566x204.png)
Physician State Society Federal and State Policy Counsel
![](https://advi.com/wp-content/uploads/2022/08/case-04-566x204.png)
Community Oncology Practice Federal and State Policy Counsel
![](https://advi.com/wp-content/uploads/2022/08/case-05-566x204.png)
Biopharmaceutical Policy Analysis and Advocacy Strategy
![](https://advi.com/wp-content/uploads/2022/08/case-17-566x204.png)
Medicaid Reimbursement Landscape Analysis
![](https://advi.com/wp-content/uploads/2022/08/case-19-566x204.png)
Self-Administered Drug Exclusion List
![](https://advi.com/wp-content/uploads/2022/08/case-03-566x204.png)
Most Favored Nation (MFN) Model
![](https://advi.com/wp-content/uploads/2022/08/case-04-566x204.png)
Insulin Coverage and Affordability
![](https://advi.com/wp-content/uploads/2022/08/case-05-566x204.png)
Mental Health Drug
![](https://advi.com/wp-content/uploads/2022/08/case-12-566x204.png)
Novel Treatment for Rare Pediatric Genetic Disorder
![](https://advi.com/wp-content/uploads/2022/08/case-13.png)
Medicare Home Infusion Therapy Benefit
![](https://advi.com/wp-content/uploads/2022/08/case-10.png)
Medicare Part D Benefit Redesign
![](https://advi.com/wp-content/uploads/2022/08/case-15-566x204.png)
“Government Negotiation” of Drug Prices
![](https://advi.com/wp-content/uploads/2022/08/case-10.png)
White Paper Development on Policy Landscape for Bio/Pharma Industry
![](https://advi.com/wp-content/uploads/2022/08/case-07.png)
Secure Channel Relationships
![](https://advi.com/wp-content/uploads/2022/08/case-10.png)
Medicare Coverage
![](https://advi.com/wp-content/uploads/2022/08/case-02-566x204.png)
AMCP Advisory Board
Market Access
![](https://advi.com/wp-content/uploads/2022/08/case-13.png)
Case Study: Parkinson’s Cell and Gene Therapy: Commercialization Strategy Workshop
![](https://advi.com/wp-content/uploads/2022/08/case-13.png)
Case Study: CMMI Engagement on CGT Model
![](https://advi.com/wp-content/uploads/2022/08/case-13.png)
Case Study: Product Ideation and Commercialization Strategies
![](https://advi.com/wp-content/uploads/2022/08/case-13.png)
Case Study: Novel Car T-Cell Reimbursement and Positioning Strategy
![](https://advi.com/wp-content/uploads/2022/08/case-07.png)
Case Study: Uncovering Potential for Products with Clinical, Epidemiology, and Real-World Cost Benefits
![](https://advi.com/wp-content/uploads/2022/08/case-13.png)
Case Study: Medical Policy Influencers Stakeholder Mapping
![](https://advi.com/wp-content/uploads/2022/08/case-13.png)
Type 2 Diabetes Digital Therapeutics Reimbursement Strategy
![](https://advi.com/wp-content/uploads/2022/08/case-12-566x204.png)
Product Positioning for a Novel Cancer Therapy
![](https://advi.com/wp-content/uploads/2022/08/case-12-566x204.png)
Launch Roadmap for a Novel Vaccine
![](https://advi.com/wp-content/uploads/2022/08/case-15-566x204.png)
Value Based Payment for Gene Therapy
![](https://advi.com/wp-content/uploads/2022/08/case-17-566x204.png)
Metastatic Melanoma Cell Therapy Launch
![](https://advi.com/wp-content/uploads/2022/08/case-20-566x204.png)
U.S. Respiratory Syncytial Virus (RSV) Vaccine
![](https://advi.com/wp-content/uploads/2022/08/case-01-566x204.png)
Gene Therapy Pricing
![](https://advi.com/wp-content/uploads/2022/08/case-02-566x204.png)
Cell Therapy Pricing
![](https://advi.com/wp-content/uploads/2022/08/case-02-566x204.png)
Pharma ELTs
![](https://advi.com/wp-content/uploads/2022/08/case-12-566x204.png)
Rare and Ultra Rare Therapeutics
![](https://advi.com/wp-content/uploads/2022/08/case-10.png)
U.S. Launch of a Ex-U.S. Oncology Agent
![](https://advi.com/wp-content/uploads/2022/08/case-15-566x204.png)
Physician-Administered Drug Commercialization
![](https://advi.com/wp-content/uploads/2022/08/case-17-566x204.png)
Next-Generation Sequencing-Based Multi-Cancer Panel
![](https://advi.com/wp-content/uploads/2022/08/case-18-566x204.png)
Liquid Biopsy Assay
![](https://advi.com/wp-content/uploads/2022/08/case-19-566x204.png)
Novel International Molecular Diagnostic System
![](https://advi.com/wp-content/uploads/2022/08/case-01-566x204.png)
Prostate Cancer Prognostic Assay
![](https://advi.com/wp-content/uploads/2022/08/case-02-566x204.png)
Evaluation and Strategic Planning for Combination Pricing
![](https://advi.com/wp-content/uploads/2022/08/case-04-566x204.png)
Value/Price Message Development for Executive Team
![](https://advi.com/wp-content/uploads/2022/08/case-05-566x204.png)
Evaluation of Indication-Based Pricing for Oncology Biologic
![](https://advi.com/wp-content/uploads/2022/08/case-13.png)
Demonstrate Value to Payers
![](https://advi.com/wp-content/uploads/2022/08/case-17-566x204.png)
Segmentation and Understanding Payers
Pharmaceuticals and Biotech
Reimbursement
![](https://advi.com/wp-content/uploads/2022/08/case-13.png)
Case Study: Reimbursement Strategy for Lifesaving Cervical Dilator
![](https://advi.com/wp-content/uploads/2022/08/case-17-566x204.png)
Occupational Therapy, Valuation of New Assessment Codes
Remote Therapeutic Monitoring
![](https://advi.com/wp-content/uploads/2022/08/case-05-566x204.png)
Cardiovascular Technologies
![](https://advi.com/wp-content/uploads/2022/08/case-13.png)
Lumbar Spine Stenosis Device
![](https://advi.com/wp-content/uploads/2022/08/case-07.png)
Non-Opioid Device Pain Relief Product
![](https://advi.com/wp-content/uploads/2022/08/case-17-566x204.png)
AI Device for Osteoporosis Assessment
Osseochondral Knee Implant
![](https://advi.com/wp-content/uploads/2022/08/case-12-566x204.png)
Wound Product
![](https://advi.com/wp-content/uploads/2022/08/case-10.png)
Diabetic Devices and Supplies
![](https://advi.com/wp-content/uploads/2022/08/case-13.png)
Commercial Strategy for Orphan Disease Commercial Strategy
![](https://advi.com/wp-content/uploads/2022/08/case-18-566x204.png)
Part A and Part B Drug Codes
![](https://advi.com/wp-content/uploads/2022/08/case-04-566x204.png)
Alzheimer’s Diagnostic and Drug
![](https://advi.com/wp-content/uploads/2022/08/case-13.png)
Pharmacogenomic Panel
![](https://advi.com/wp-content/uploads/2022/08/case-17-566x204.png)
Osteoarthritis Pain Drug
![](https://advi.com/wp-content/uploads/2022/08/case-07.png)
Colorectal Cancer Screening Test
![](https://advi.com/wp-content/uploads/2022/08/case-20-566x204.png)
Minimal Residual Disease Test
![](https://advi.com/wp-content/uploads/2022/08/case-18-566x204.png)
Payer Reimbursement Landscape
![](https://advi.com/wp-content/uploads/2022/08/case-10.png)
CPT Coding
![](https://advi.com/wp-content/uploads/2022/08/case-10.png)
HCPCS Coding
![](https://advi.com/wp-content/uploads/2022/08/case-13.png)
Payer Workshops on Clinical Endpoints and P&R for Novel Biologic
Strategic Analytics, Value and Economics
![](https://advi.com/wp-content/uploads/2022/08/case-13.png)
Case Study: Medicare Part D Liability Model
![](https://advi.com/wp-content/uploads/2024/06/Insights_header_bg3-566x204.jpg)
Case Study: Medicare Utilization and Cost Trends for CAR-T Cell Therapies Across Settings of Care in the Treatment of Diffuse Large B-Cell Lymphoma
![](https://advi.com/wp-content/uploads/2022/08/case-19-566x204.png)
Case Study: Assessing PD-1/PD-L1 Usage in the Enhancing Oncology Model
![](https://advi.com/wp-content/uploads/2022/08/case-13.png)
Case Study: Patient Population Analysis
![](https://advi.com/wp-content/uploads/2022/08/case-13.png)
Retrospective Study: SGLT-2 Inhibitors Rx Disparities and Affordability Among Medicare Patients with Diabetes
![](https://advi.com/wp-content/uploads/2022/08/case-13.png)
Assessing the Hypertension Market in Medicare and Medicaid Populations
![](https://advi.com/wp-content/uploads/2022/08/case-02-566x204.png)
Go-to-Market Strategy Development and Execution for Progyny
![](https://advi.com/wp-content/uploads/2022/08/case-03-566x204.png)
Strategic Planning for Part B Launch
![](https://advi.com/wp-content/uploads/2022/08/case-19-566x204.png)
Strategic Partnerships for Digital Health Clients
![](https://advi.com/wp-content/uploads/2022/08/case-01-566x204.png)
Device Concept, Creation, and Commercialization